These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11163475)

  • 1. Strategies of immunization against mucosal infections.
    Russell MW; Martin MH; Wu HY; Hollingshead SK; Moldoveanu Z; Mestecky J
    Vaccine; 2000 Dec; 19 Suppl 1():S122-7. PubMed ID: 11163475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immune system: implications in otitis media with effusion.
    Bernstein JM; Ogra PL
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):326-32. PubMed ID: 6778340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development.
    Kiyono H; Bienenstock J; McGhee JR; Ernst PB
    Reg Immunol; 1992; 4(2):54-62. PubMed ID: 1503889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
    Kunisawa J; Gohda M; Kiyono H
    Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
    Kodama S; Hirano T; Abe N; Suzuki M
    Acta Otolaryngol; 2007 Aug; 127(8):809-15. PubMed ID: 17762989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
    Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
    J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M cell-targeted ocular immunization: effect on immunoglobulins in tears, feces, and serum.
    Phillips TE; Sharp J; Rodgers K; Liu H
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1533-9. PubMed ID: 19892871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nasopharynx and the middle ear. Inflammatory reactions in middle ear disease.
    Rynnel-Dagöö B; Agren K
    Vaccine; 2000 Dec; 19 Suppl 1():S26-31. PubMed ID: 11163459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Th1 and Th2 cells for mucosal IgA responses.
    Yamamoto M; Vancott JL; Okahashi N; Marinaro M; Kiyono H; Fujihashi K; Jackson RJ; Chatfield SN; Bluethmann H; McGhee JR
    Ann N Y Acad Sci; 1996 Feb; 778():64-71. PubMed ID: 8611017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory IgA- and IgG-coated bacteria in the nasopharynx of children. An immunofluorescence study.
    Stenfors LE; Räisänen S
    Acta Otolaryngol; 1991; 111(6):1139-45. PubMed ID: 1763637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system.
    McGhee JR; Kiyono H; Michalek SM; Mestecky J
    Antonie Van Leeuwenhoek; 1987; 53(6):537-43. PubMed ID: 3329827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunoreactivity in experimental pneumococcal otitis media.
    Svinhufvud M; Hellström S; Hermansson A; Prellner K
    APMIS; 1992 Nov; 100(11):1015-21. PubMed ID: 1472361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of oral immunization.
    Ruedl C; Wolf H
    Int Arch Allergy Immunol; 1995 Dec; 108(4):334-9. PubMed ID: 7580304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunity of the middle ear.
    Mogi G
    Acta Otolaryngol Suppl; 1984; 414():127-30. PubMed ID: 6335942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
    Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
    Rochereau N; Pavot V; Verrier B; Jospin F; Ensinas A; Genin C; Corthésy B; Paul S
    J Allergy Clin Immunol; 2016 Jan; 137(1):214-222.e2. PubMed ID: 26414879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative aspects of the mucosal immunity and bacteriology of the nasopharynx and middle ear cavity. Studies on children with clinically different forms of otitis media.
    Sørensen CH
    APMIS Suppl; 1990; 16():1-41. PubMed ID: 2192745
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic aspects of otitis media with effusion.
    Mogi G; Watanabe N; Maeda S; Umehara T
    Acta Otorhinolaryngol Belg; 1983; 37(1):5-21. PubMed ID: 6351530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.